Cagrilintide | 5mg

$83.00 USD

Sale Sold out

Shipping calculated at checkout.

Quantity

Quick Links: Overview Usage Notice References

Overview

Cagrilintide is a long-acting amylin receptor agonist studied for its appetite-suppressing and gastric-emptying delaying effects. In metabolic research models, it has been evaluated in combination with GLP-1 receptor agonists such as Semaglutide and Tirzepatide for enhanced weight loss and improved metabolic outcomes. Cagrilintide acts on the hypothalamus to regulate satiety signals, making it a promising target for multi-hormonal obesity therapy.

Quantity:

5mg per vial

Purity:

≥99% (HPLC Verified)

Format:

Lyophilized powder

Storage:

Store at -20°C, protect from light and moisture

Usage

Solvent:

Bacteriostatic Water

Concentration:

Add 1mL BAC water = 5mg/mL solution

Stability:

Store reconstituted vial at 2°C–8°C and use within 30 days

Dose:

600mcg = 0.12mL = ~12 units (using 100iu insulin syringe)

Frequency:

1x weekly; often studied in combination with GLP-1 analogs

Dosing based on 5mg/mL concentration. For laboratory reference use only.

Notice

Research Use:

Not for human or veterinary use. For educational and laboratory study only.

Qualified Use:

For licensed researchers and laboratory professionals

Scientific Basis:

Information reflects obesity, satiety, and endocrine regulation models

Reminder:

Do not misbrand, misuse, or misrepresent this compound

References

Lancet (2021):

Cagrilintide with Semaglutide for Weight Loss

Diabetes Obes Metab (2022):

Amylin Analogues in Appetite Regulation

Clinical Trials:

Cagrilintide Obesity Treatment Study

Disclaimer

Cagrilintide is a research compound not approved for medical use. AlphaBoost supplies this product for research and reference purposes only. It is not for human or veterinary use.

Category: Weight Loss
Use: Licensed research professionals only
Fulfillment: U.S. facility — 24-hour dispatch

View full details View full details

Item added to your cart

Cagrilintide | 5mg